Cite
HARVARD Citation
Stromecki, M. et al. (2018). Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma. Molecular oncology. 12 (4), pp. 495-513. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stromecki, M. et al. (2018). Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma. Molecular oncology. 12 (4), pp. 495-513. [Online].